121
Views
7
CrossRef citations to date
0
Altmetric
NEW METHODOLOGIES

Two-Staged Procedure of Portal Ligation and Hepatectomy Monitored by ICG Clearance

, MD, PhD, , MD, DEAA, , MD, , MD, DSc & , MD, DSc, FACS
Pages 63-68 | Received 13 Apr 2008, Accepted 01 Jul 2008, Published online: 09 Jul 2009

REFERENCES

  • Vauthey J N, Baer H U, Guastella T, et al. Comparison of outcome between extended and nonextended liver resections for neoplasms. Surgery 1993; 114: 968–975
  • Tsuzuki T, Sugioka A, Ueda M, et al. Hepatic resection for hepatocellular carcinoma. Surgery 1990; 107: 511–520
  • Okamoto E, Kyo A, Yamanaka N, et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984; 95: 586–592
  • Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176–1181
  • Vauthey J N, Chaoui A, Do K A, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127: 512–519
  • Capussotti L, Borgonovo G, Bouzari H, et al. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg 1994; 81: 427–431
  • Cherrick G R, Stein S W, Leevy C M, et al. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960; 39: 592–600
  • Broering D C, Hillert C, Krupski G, et al. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002; 6: 905–913
  • Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000; 232: 665–672
  • Wheeler H O, Cranstone W I, Meltzer J I. Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol Med 1958; 99: 11–14
  • Benya R, Quintana J, Brundage B. Adverse reactions to indocyanine green: a case report and a review of the literature. Cathet Cardiovasc Diagn 1989; 17: 231–233
  • Paumgartner G, Huber J, Grabner G. [Kinetics of hepatic dye absorption for indocyanine green. Influence of bilirubin and sodium glycocholate]. [German]. Experientia 1969; 25: 1219–1223
  • Paumgartner G. The handling of indocyanine green by the liver. Schweiz Med Wochenschr 1975; 105(17 Suppl)1–30
  • Faybik P, Hetz H. Plasma disappearance rate of indocyanine green in liver dysfunction. Transplant Proc 2006; 38: 801–802
  • Couinaud C. [Anatomic principles of left and right regulated hepatectomy: technics]. [French]. J Chir (Paris) 1954; 70: 933–966
  • Hashimoto M, Sanjo K. Functional capacity of the liver after two-thirds partial hepatectomy in the rat. Surgery 1997; 121: 690–697
  • Fazakas J, Mandli T, Ther G, et al. Evaluation of liver function for hepatic resection. Transplant Proc 2006; 38: 798–800
  • Schneider P D. Preoperative assessment of liver function. Surg Clin North Am 2004; 84: 355–373
  • Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999; 134: 984–992
  • Abdalla E K, Hicks M E, Vauthey J N. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88: 165–175
  • Rous P, Larimore L D. Relation of the portal blood to liver maintenance. A demonstration of liver atrophy conditional on compensation. J Exp Med 1920; 31: 606–632
  • Takayasu K, Muramatsu Y, Shima Y, et al. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 1986; 160: 389–393
  • Honjo I, Suzuki T, Ozawa K, et al. Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg 1975; 130: 296–302
  • Makuuchi M, Thai B L, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107: 521–527
  • Makuuchi M, Kosuge T, Lygidakis N J. New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma–an old problem revisited. Hepatogastroenterology 1991; 38: 329–336
  • Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231: 480–486
  • Lau H, Man K, Fan S T, et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatoctomy. Br J Surg 1997; 84: 1255–1259
  • Hemming A W, Scudamore C H, Shackleton C R, et al. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992; 163: 515–518

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.